NovaXS Biotech wins Pad-13 Pitch Competition and is voted Audience Favorite
Updated: Apr 15
NovaXS Biotech Corp. is honored to be selected as the champion and audience favorite of Berkeley SkyDeck Pad-13 Pitch Competition. Special thanks to National Science Foundation (NSF) I-Corp Team, Todd Miller, Carl Bouthillette
and Dave Weiner for helping restructure our value proposition and select the initial target market.
Thanks to SkyDeck mentors Cathy Farmer , Darren Cooke, Caroline Winnett and Sibyl Chen for all the industry insights, valuable connections and advice!
NovaXS Biotech will continue building advanced drug delivery platform that makes daily self-injections as easy as making your daily espresso.
Alina Su, CEO of NovaXS, is currently finishing
her Ph.D at Harvard Medical School.
Last Thursday, NovaXS Biotech won SkyDeck’s Pad-13 Pitch Competition, where eleven Pad-13 companies showcased their products to SkyDeck advisors, mentors, alumni and investors. Alina Su, the founder and CEO of NovaXS, was also voted Audience Favorite.
To read to the full article please go to: